TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,049 Cr | ₹905 Cr | ₹186 Cr | ₹-134 Cr | ₹750 Cr |
What is the latest Net Current Assets ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,049 Cr |
| Mar2025 | ₹905 Cr |
| Mar2024 | ₹186 Cr |
| Mar2023 | ₹-134 Cr |
| Mar2022 | ₹750 Cr |
How is Net Current Assets of TORRENT PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,049 Cr | 15.81 | |
| Mar2025 | ₹905 Cr | 386.16 | |
| Mar2024 | ₹186 Cr | Positive | |
| Mar2023 | ₹-134 Cr | Negative | |
| Mar2022 | ₹750 Cr | - | |
Compare Net Current Assets of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹152,758.8 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
| MANKIND PHARMA | ₹104,478.0 Cr | 7% | 2% | 7.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.5% |
0.7% |
37.1% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses